SRNE - Sorrento Therapeutics Inc
Previous close
0.006
0 0%
Share volume: 229,119
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.00%
Summary score
7%
Profitability
0%
Dept financing
18%
Liquidity
26%
Performance
6%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.42%
Return on assets
-4.38%
Return on sales
-515.78%
Return on invested capital
-11.55%
Total debt ratio
70.99%
Debt ratio change over timeo
-11.71%
Current Ratio
1.07%
Quick Ratio
0.92%
Cash Position Ratio
0.89%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-48.76%
Return on assets
-8.02%
Return on sales
-442.99%
Return on invested capital
-20.45%
Total debt ratio
70.06%
Debt ratio change over timeo
-4.83%
Current Ratio
0.88%
Quick Ratio
0.85%
Cash Position Ratio
0.54%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-40.9%
Return on assets
-8.01%
Return on sales
-410.28%
Return on invested capital
-20.8%
Total debt ratio
65.88%
Debt ratio change over time
-4.28%
Current Ratio
1.15%
Quick Ratio
1.13%
Cash Position Ratio
0.82%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.02%
Return on assets
-89.87%
Return on sales
3569.28%
Return on invested capital
-165.62%
Total debt ratio
-1171.09%
Debt ratio change over time
-11.71%
Current Ratio
-11%
Quick Ratio
-6.83%
Cash Position Ratio
-8.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRNE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.42% | -3.65% | 12.3% | 6.42% |
| Return on assets | -4.38% | 3.5% | 3.6% | 5.35% |
| Return on sales | -515.78% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -11.55% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 70.99% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -11.71% | 224.03% | 6.03% | 1.46% |
| Dept financing | 18% | 50% | 19% | 8% |
| Current Ratio | 0.88% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0.85% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 0.54% | 1.41% | 0.73% | 1.41% |
| Liquididy | 32% | 34% | 61% | 74% |
| Short-term ratios | SRNE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -48.76% | -16.17% | 18.05% | 7.63% |
| Return on assets | -8.02% | 2.71% | 3.58% | 5.03% |
| Return on sales | -442.99% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -20.45% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 70.06% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -4.83% | 851.68% | 10.97% | 0.58% |
| Dept financing | 18% | 50% | 21% | 8% |
| Current Ratio | 0.88% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0.85% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 0.54% | 1.41% | 0.73% | 1.41% |
| Liquididy | 23% | 56% | 40% | 75% |